TY - JOUR
T1 - Recapitulation of Human Embryonic Heartbeat to Promote Differentiation of Hepatic Endoderm to Hepatoblasts
AU - Yoshimoto, Koki
AU - Minier, Nicolas
AU - Yang, Jiandong
AU - Imamura, Satoshi
AU - Stocking, Kaylene
AU - Patel, Janmesh
AU - Terada, Shiho
AU - Hirai, Yoshikazu
AU - Kamei, Ken Ichiro
N1 - Publisher Copyright:
© Copyright © 2020 Yoshimoto, Minier, Yang, Imamura, Stocking, Patel, Terada, Hirai and Kamei.
PY - 2020/9/8
Y1 - 2020/9/8
N2 - Hepatic development requires multiple sequential physicochemical environmental changes in an embryo, and human pluripotent stem cells (hPSCs) allow for the elucidation of this embryonic developmental process. However, the current in vitro methods for hPSC-hepatic differentiation, which employ various biochemical substances, produce hPSC-derived hepatocytes with less functionality than primary hepatocytes, due to a lack of physical stimuli, such as heart beating. Here, we developed a microfluidic platform that recapitulates the beating of a human embryonic heart to improve the functionality of hepatoblasts derived from hepatic endoderm (HE) in vitro. This microfluidic platform facilitates the application of multiple mechanical stretching forces, to mimic heart beating, to cultured hepatic endoderm cells to identify the optimal stimuli. Results show that stimulated HE-derived hepatoblasts increased cytochrome P450 3A (CYP3A) metabolic activity, as well as the expression of hepatoblast functional markers (albumin, cytokeratin 19 and CYP3A7), compared to unstimulated hepatoblasts. This approach of hepatic differentiation from hPSCs with the application of mechanical stimuli will facilitate improved methods for studying human embryonic liver development, as well as accurate pharmacological testing with functional liver cells.
AB - Hepatic development requires multiple sequential physicochemical environmental changes in an embryo, and human pluripotent stem cells (hPSCs) allow for the elucidation of this embryonic developmental process. However, the current in vitro methods for hPSC-hepatic differentiation, which employ various biochemical substances, produce hPSC-derived hepatocytes with less functionality than primary hepatocytes, due to a lack of physical stimuli, such as heart beating. Here, we developed a microfluidic platform that recapitulates the beating of a human embryonic heart to improve the functionality of hepatoblasts derived from hepatic endoderm (HE) in vitro. This microfluidic platform facilitates the application of multiple mechanical stretching forces, to mimic heart beating, to cultured hepatic endoderm cells to identify the optimal stimuli. Results show that stimulated HE-derived hepatoblasts increased cytochrome P450 3A (CYP3A) metabolic activity, as well as the expression of hepatoblast functional markers (albumin, cytokeratin 19 and CYP3A7), compared to unstimulated hepatoblasts. This approach of hepatic differentiation from hPSCs with the application of mechanical stimuli will facilitate improved methods for studying human embryonic liver development, as well as accurate pharmacological testing with functional liver cells.
KW - heart beating
KW - hepatic endoderm
KW - hepatoblast
KW - human embryonic stem cells (hESC)
KW - mechanical stimulation
KW - microfluidic device
UR - http://www.scopus.com/inward/record.url?scp=85091426936&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091426936&partnerID=8YFLogxK
U2 - 10.3389/fbioe.2020.568092
DO - 10.3389/fbioe.2020.568092
M3 - Article
AN - SCOPUS:85091426936
SN - 2296-4185
VL - 8
JO - Frontiers in Bioengineering and Biotechnology
JF - Frontiers in Bioengineering and Biotechnology
M1 - 568092
ER -